: *
!"
#$%&%' "( ) .
!+, -" . &
4
! " # $ %&
'()
&
1 + , ) - . /
0
&
" 1) ' )
* 1 2
3
1 - !
"
#$%
# & ' (
& '
&
.
2 - % + , !
"
#$%
# & ' (
& '
&
.
3 - !
"
#$%
# & ' (
& '
&
.
! / #
$ % / # 2 / '( ) 96
/ ,' ' 72
: 14 / 1 / 96 :
27 / 2 / 96
! "
:
$ % & ' () * + , -" . / % $ , 0 , 0 1, * + , , 2 ,
"3 . 2 3 3 3 , &
, 5 $ % 5 6
" $ 1
780 ! 9 : , ;
"<1, . 3= !3 & 31, !+> ( 2 ? 5 @"
4 - 3< B !3 C
8% &, 1
&,
" $ 1
, D80 9 : , ; E
-, , & F
"6
.
E&, &
: G &F E&, )
?B
"6 H; , ! 32 -, , & F E 1
! , / & 3 & 3$ , 3 I !3 % 3 B
-, 5 2 " ! " "6 J B
& $ 8% K L @ & B 8
/ 0 8 2 $ H"3 H5& 2 $ 38 3 5 ! H&, LPS
"6 P , B 0 CQ .
B & $ KLB&
4
! C -" ! , K " B &, H" &
45
" 2 ? 5&, , ! 0 .
8% & $ ! !3 5&,
5 / 0 8 2 $
"6 " , S 8%
.
! % : J B T
" $ 1
% & $ ! UD B & $ , D80 9 : , ;
! , 3/
U31 3 , 3<+
) 05 / 0 P<
.(
J B T
" $ 1
, <+ 8% & $ ! UD B & $ , D80 9 : , ;
"6 .
!? & XY
$ : B
" B G P / 5 JZ[\
= $ % , %, "< ? , " C -
&
J B G % , "3 $
3
1 D80 9 : , ; 780 L B ] 1 9 YB G 7^
6 .
: &
" 8 :
1 B
" $ 1 9 : , ; H 5;
.FST
! "
< =# 8 . 0
9 /,;
>;
) 1 ( A4B /4,C
&
; >D / % ( .E>
B 0
# >
) 2 (.
8 > F A>C # >0
A4B
# ) 3 .(
G /
H 7I
& ># >,'# >0 J>1 # 1 % KL9# 8 9 , 0 )
4 .(
M>N O >P1 # 1 >% 8 >9 ,
J + #
#
; ) 5 ( G 3 9R,;
# 1 >>%
J9>>
M>>N >> G />> A>>4B & >>S
J >> T>> T>> D
>>#
>>;
) 6 .(
8 >>9 ,
7V G # 1 %
5 G =# I <
>#
>99
/W N & J; X,% &
>%
X,
J
# 9;
) 7 .(
/4 >% /> >P4B ! >% >%
!9; >,;
+ >W & # ; P7V ! % 3 9Z >#
>
.
T " ! % )
X,%
( > =# I P7V K 0 %
) (ANS
4 J1 > 8[ >( >;
N )
8 .(
3> > W > # P7V 5B #
8 F
N N 3 : 3 :
# 9 . N 3 >:
>
]> /> 4 ^ > [ ># _ ,V 3 "
>#
>
>>
N 3 >>:
3 >> " >>
` >>9 # >>;
P>>7V
" X,%
# ) 9 .(
3 & ># ; ># > >;
]b>>% >> W >> #
` 4>>%
>>;
c>> d >>I >>.
;
T " e 7 I
` ,V
# >99 ) 10 .(
; 1 + > N ` >1 ` g>0# A4B T "
& / # ; P7V ` 4>%
>;
+ > # >
_ ,h / I ; K % P4B &
# /
>d />
75 80 > 5> >e >;
>
5 > >P4B
# 9;
) 12 11 .(
% ; K > > >G A>4B # 4%
; T "
>
>
i=> #
K / 0
' "
> F />Z j 3 >, N
# 9 ` ( 3 ;
, 1 0# k 8 >e
/>>
>>%
. >> J; l>>N & >> ,; >>
j # ; m>N /> > j > 8 0 l 12
9 8 9 , / :;
K 5 #
>
>;
>
1
3>b T "
>%
20 % > 4;
>%
33 %
3>b > 4; /> ( / J;
> F o>Z
; # .
' "
6M(
&
;
& T
; # N 5 G T 6M( /
>W # 9 ,;
>#
>
>' "
>G >
>;
>>
>>
/>> >>
>>
>>
>>; # N
` ( 3 : # 9 ,;
/W >
6M( / ,h
> p > T 8 > F /> >W9#
p % 4,V K
;
# . 3 9R,;
/>
>> # 1 >>% 8 >>9 , 8 >>. >> >>L9#
; 1 P4B T "
8 /W 3 / ;
/ %
6 5 # > > # 1 % 8 9 , / :;
K ; J
#
; ) 13 .(
. /0 1# % 6 ; S ( J; lN /# T
5 # > & > # 1 % 8 N 3 ,
K 3 0 4 0 S
>;
>
1
P4B T "
j # ; + >W 8 >0 l> >
% / .
E&, &
!+> ( , !+ ^
W S ( J; lN j
# J; lN q d
>> F # T>> >> >>'Z />0 1#
>> + >>W .
3>>
J; lN 32 % 8 0 l j # /
d
/ 7
5# 'Z
8
>%
3 >, )
Train
( 8
>%
>>0 ) (Lps
8
>>%
3 >>0 4 5>>, # 6 >>7#
) ( Flux
8
>>%
` >> 9 ) (Cont
>> K >>01 .
24
` 1 mN V % 8
; !> # " />
8 >;
/>,;
; PC 9 & # " % 9 "
)
Forced
Swimming Test
( 7 I / 8 # / C FST
15 r & /1 B / %
c,V / 5 40
bB
20 % # 0 4N m9C > <" > D# / s$
5>D# m:B / T I / ( & N 9 B '!
.
G &F &, KLB&
24 mN V % + > >; /> /> >% 9 "
8 ; ;
5>, # 6 >7# > 3 , 0
3 0 4 8
/ 0 4 # + >4 >; / & > & +
& > C 0 W 5# V
Lipopolysaccharide
>7 I / > c> B :>e & 5 > /> LPS
` 4D#
c J NLPS
1 4 # + 3 >% ` >4D#
c B ) 13 (.
, D^ <6 H 5;
) (FST
+ >
8 >;
/>,;
>
>;
J; l>N
& # "
> 8 >P. > >% & ># " T> / FST
& C 0
# 3> /
8 # / 8 ; / A 5
>0 4N 6 >r & />1 B
B <" D# s$
. / / <" c,V >
/>>
8 >>;
>>Z <" & & >> # & >> 9>> >>C
9 . & # ( >; &
& >9V /> 8 >
P. &" FST
.
< B KLB&
` 9 0
u ; / 9 , /#
3 >, 5> N T> 3 >, 4
/ :;
V % 5 # &
20 />1 B #
8 # / 45
& V % + W /1 B
18 6 r v / k" 0= /1 B #
4 > J > /9 1# / .
>9 , />#
30 k" /1 B 3
J /1 B
# "
; % ' 1# 9
/ 8 ; & > # ; 3 0 4
5 / 0
# >4 + >
5 > / # " & / ' 3 0 4 H B
I I
. 8 ;
6 7# 0
c>> m>>N 3 >>0 4 />># u >>; LPS
5>>D# !>> # " >> >> >>9 ,
% '!
8 ;
/># '!
/> MF
% 8 ; > M>k <" /> " >% % 5# > />
> >I .
c >b# > 9> ` >d
w % 12 / 12 . 24 3 >I" mN V %
3 , /04C
# "
; > > B > />% ;
! # " i7= # /4 % / + # >% C
. ! B & 5 1 ; U% &, _
; j / ,;
! >% : % &
,;
> >,; J ` 7D#IKA
# x
"
.
5 1 ;
!
/ , ; > [ T 9 : % "
; y9 4X,%
; 1 "
T ` >7D#
#"
- 9 Z
ZellBioGMbH
/> W >#
9 B 5 4D
.
N m % C <" > > 0 + > #
+ , & I b1#
/ , ; % s %
m
100 4PH
/ 7 ` >>4D# : >>% >>
! >>% PBS
> ,; ,;
) 100 >4 # >
> >
1
4 # (
>g N S ` 4D#
/>4( # /> PBS
/ , ; .
z > ( >B x # & N
"
. & , #" " mN / ,
;
ml
100 / , ; 90
# /1 B 37
/C %
/ . / , ; mX%
100µl
>% 9 9 >
8 # / Ab
60 ># />1 B 37
/> />C
. : % / , ; 300µl
/%
c B %
100ml
` 4D#
/ HRP
/ , >;
/> > >
8 # 30 # /1 B 37
> /> /C .
>
+ , / , ; : % 300µl
c B 99 / >0
. mX%
90µl
J9 # 8 D:>e /> 0 %
8 # / 15
# /1 B 37
/> /C
. 5( # 3 & N 30µl
>99 {>B # ` 4D#
/4>e $ /> ,
>;
| ># ` >d 450nm
: >% > > h B v # X%
% % 0( ,
99 ;
/>
% 0(
78 5000
+ N
4 # >
/P% D#
.
, ; > ;
& # " mN J N v : >% FST
& ># "
T
/ , ; c 8 . 8 P. L9# / / 0
& > 0 / LPS
8 >;
5> 4D > c>
. ; & # " mN & # " J N >; > FST
>
& ># " : >% >
>:CT
/> , ]b>%
9G#
05 / 0
α<
> 5 4D .
>;
>
>;
: % P4B
ANOVA
: >% > />; T
+ /=0 SPSS
22
#
9 B 5 4D
.
! %
` FST
v
& # "
; / , T
; > > >:C
& # "
, ` C FST
1 > "
>%
. v >
& # "
:CT
/ , & # " mN & # " J N
& # " ` 9 & FST
>#
>;
8 >: />
> >C & ># " m>N J >N v > 3 > 9G#
) 151 154 M=
001 M=
/ 0
P>
.(
& ># " v >
T
> >0 > & ># " m>N & # " J N & # "
& FST
#
; ]b>% / 001
/ 0
α>
8 >:
>>C & >># " m>>N J >>N v >> 3 >> >>9G#
) 189 211 M=
001 M=
/ 0
P<
( . & ># " v >
T
> 3 >, > & ># " m>N & ># " J N & # "
& FST
#
; ]b% / 001
/ 0
α>
8 >:
>>C & >># " m>>N J >>N v >> 3 >> >>9G#
) 187 164 M=
001 M=
/ 0
P<
( . & ># " v >
T
5>, # 6 >7# > & ># " mN & # " J N & # " 3 0 4 & FST
# >;
]b>% />
001 / 0
α>
& ># " mN J N v 3 9G# 8 :
C ) 186 197 M=
001 M=
/ 0
P<
(.
`
" $ 1
9 : , ;
,>> ` >C 2
m >> 5>> 4D ` >C v >>
ANOVA
&
#
; > 5B >( / 3 ! > #
>;
% 9G# 8 : )
13
= 05 F
/ 0
= 014 α
/ 0
= (.Sig
> > P 1G & # " v >;
ANOVA
, ` C 3
% #"
. & v 3
# >9;
/>
K 3 ! #
; 1
T "
> >P4B
9G# ` 9 / P0 3 ,
>, >
. 3 ! > #
K ; 1
T "
3 >, > >P4B
>>9G# >>0 >> />> P>>0
>>#
>>
) 05 / 0
P<
( .
K 3 ! #
; 1
T "
> >P4B
3 , > /> P>0 >9G# 3 >0 4
>, >
.
K 3 ! #
; 1
T "
P4B
>>9G# ` >> 9 >> />> P>>0 >>0
>>#
>>
) 05 / 0
P<
.(
K 3 ! #
>
>;
>
1 T> "
, 1 . $"< & . 5 KQ ` !
L " & 7
&, _ > 8 2 $
>9G# 3 >0 4 > / P0 0 P4B
# ) 05 / 0
P<
(.
K 3 ! #
; >
1 T> "
>P4B
9G# 3 0 4 / P0 ` 9
, .
a&"^
2 . J B , ; ! , 9 b , & K 8YB `
" $ 1
D80 9 : , ;
Sig. F " /C ;x # x,C 014
/
0 13 3 3609384 ; 3
28 2447158 ; &
31 6056542 5
a&"^
3 .
` +B H 5;
D B a&"^
ANOVA
{ ;
& % 3 ! # ;
(I-J) Sig.
95
%
& 9 ,d /4e
&
3 N &
[
` 9 3 ,
227 - 002 / 0 631 - 175
* 0 907 - 011 / 1314 0 506 -
-
3 0 4 325
- 038 / 0 728 - 78
3 ,
` 9 227
002 / 0 175 - 631
* 0 682 - 0032 / 0 1086 - 278 -
3 0 4 97
- 009 / 0 500 - 306
0
* ` 9 910 011 / 0 506 1314
* 3 , 682 0032 / 0 278 1086
3 0 4 585*
022 / 0 181 988
3 0 4
` 9 325
038 / 0 78 - 728
3 , 97
099 / 0 306 - 500
* 0 585 - 022 / 0 988 - 181 - #$V
*
&
9;
9G# 8 : 3 ! #
;
% .
& XY
!?
$
& # 9Z 5# V % 9;• 9 0
&" >>P' 5>> I
>>
. I 9>> 5>># V 5>># V 3>>
# 9 ) 5 ( ; >9 > / >
/>4,C >
z P B V P4B #$%
# >P4B 9
> >P4B >% /> >W9# P' .
>
>.
J X,% & 0
# /> 4= 3 9R,;
N 3 : X,% / 4=
A>4B
J >>
>>#
>>
) 14 ( >>G 8[ >>D 3>> >>9
; 1
J K; T "
# . 3> />,;
> >1 A>C # g /P9C K; 9 8$ G
# ) 15 ( 5># V > />
>9#
% B V P4B bI
) 16 .(
8 >9 , /># + >W
/ /Z 8 # # 1 % />
>d > ># 5>#
(
#
9 '# 8 F 3
. 3> v
& J; lN
# 9;
& > >; I 9> />P9C /
/>>4I # & >>
>>0 >>,
& >>,;
/>>
/>>
; > & ># " m>N & ># " J N FST
>0 ) 211
=
M FST Post
5> 1#
189
=
M FST Pre
(
>> />>0 1#
` >> 9 >>
) 151
=
M FST Pre
5>> 1#
154
=
M FST Post
(
# "
& ># 5 > / / e
/> # AC # ; /4I # &
# & > > / /
K>h$V >, >
) 16 (.
K A 3 ,; /
; >
1 T> "
>9G# J ` 9 / P0 0
13 % &
#
;
/ 3 , / (
3 ! # 9 > >0 > / > # & # " J NFST
) 187
= >> M
189
= ( M
>>9 , />># & >> N 4
/ :;
K; ; 8 : # ; #
>#
>
/>
0 ;
211 / (
>P' ; 3 , />
>
164
= > ( M
a&"^
1 . H 5;
UC^T
! b & G
H 5;
& $ ` , G &F
FST
FST1-FST2
&
3 N
&
T [ Sig. (2-
tailed)
` 9 7 - 1 2 - 052 / 0
0 34 - 10 - 6 - 011 / 0
3 , 15 29 11
023 / 0
3 0 4 11 - 9 - 24 - 03 / 0
e / Sig. (2-tailed) 05<
/ 0 :e 9 N [ /9#
, 3 9R,; ! 8 e 3 ! B /9# & T
#
&
C 9G# 8 : / : .
& # " J N ; ,
. 3> 3 > L
; / /
5# FST
& # ; > D >
>>0 / >> >> >>;
>>
3 >>9
#
&
# 1 >% 8 >9 , /# + W / /W
#
W9# 0 J; /
.
3 ! # ;
>
1 > >P4B T> "
0 24 % J > 3> /> % 3 ,
9G#
# . & > v 3 >#
>9;
>'9 /> />
3 ,
# J; c d
K>h$V >0 >
> 4 >9 >W > :# 8 . K > J > >'# > /
; 1 T> D J; > AC # P4B T "
" K; A4B X,%
. v v 3 & >%
& ,;
K;
I / P
' "
K >
>;
8 ; K % /0 1# K;
) 17 ( .
#
&
v K ,G ' "
9 / ; /W S ( J; lN
# 1 % 8 9 , /# + W /
# x >#
J /
G >;
>
1 >P4B T> "
/W A>4B > X,>% /> 4= 8 >
9 5 G .
` 9 / P0 3 ,
, AC #
J 5# '#
; 1 /> > T "
K J 1# ` ( ;
>
>;
8 >;
0 / # 1 % 9 , /#
4 / :;
M W
% ) 12 % ` > 9 / P0 (
0 9G# 8 : 3 # .
v > 3 / # & 9 >
u ; 8 > F /> P >% 9# ; lN j >> A>>B G # X,>>% & >> 5 >>G >>% A>>7V
w% 0
3 ' % >% > j >
) 18 (.
>S ( J; l>N v % 9 v 3 )
>,
1 ( &
# 9;
u ; & 0 /
/>4I #
'C K; ;
/ ; K I
#
) ; ( FST
> < =# ." 'C K;
A4B ) J ;
1
T "
(.
3> >
# 1 % 9 , /# T + W C
# (
> T> >." > x # )
19 (
3 >, > & ># " m>N ;
&
9;
> > ; >9 ` 9 '#
0
# >
. & >9V /> 3 >0 4 6 >7#
>9G# J; > A>C # >0 > v> & # ; /> />C > ` >( 3> FST
>;
, ` C 3
#
&
9 , /# T + W / :
1# / 3 0 4 5, # 6 7# # 1 % &
5 / 0
4 # +
# >9G# 8 F x #
; P4B 1
T "
j # ; 8 0
0 .
K 9G# 8 F + V 3 9R,;
>;
> /> P>0 3 >0 4 6 >7# >
3 >, ` > 9 & >
>9;
.E>
>P€#
/>#
>>;
9 , 5> N
>;
>'# >0 >S >
/P9C ;
0 :9#
# .
/ d J; lN v /e$I S (
&
# >;
/>
v J AC # 0
& >#
>;
>
> D
& # "
>0 FST
>#
>
+ >W 3 >9R,;
V >% > & > # 1 >% 9 , /#
20 > > #
8 # / /1 B 45
/ :; 'Z ` d /1 B 8
>;
/>>Z >>0
>>,
>>
& >># >>9G# J >> x >>#
D 'C > 5> B >1# /> &" >1# >#
J;
#
; & J; lN 3 v $G >#
>9;
K 9G# J AC # 0 /
>;
1 A>4B T> "
8 >;
>0 >
>#
>
) , 1 ( > & > # 1 % 9 , /# T
3 0 4 0 S 6 7#
# x >#
9G# J K
>;
>
1 T> "
A4B 8 ; 0 .
& ># u >; J; lN 3 # T> A> K >! >L 3 ,
& >># T> >9 # 1 >% > >9 , />#
# & 9V / /9 #
J; lN
B L # 9 "
.
L B ,"0 &
/> / 4 >#
3> + >W >N
>
> # >,9; >% _ >e 7I >1 ` >,
!% X%
K .
References
1. Blumenthal JA, Califf R, Williams RS, Hindman M. Cardiac rehabilitation: a new frontier for behavioral medicine. J Cardiac Rehabil. 1983; 3: 637-656.
2. Naughton J, Bruhn JG, Lategola MT.
Effects of physical training on physiologic and behavioral characteristics of cardiac patients. Arch Phys Med Rehabil. 1968; 49:
131-137.
3. Blumenthal JA, Emery CF, Walsh MA, Cox DR, Kuhn CM, Williams RB, et al.
Exercise training in healthy type A middle- aged men: effects on behavioral and cardiovascular responses. Psychosomatic Med. 1988; 50(4): 418-433.
4. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al.
Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosomatic Med. 2004;
66(3): 305-315.
5. Maines TY, Lavie CJ, Milani RV, Cassidy MM, Gilliland YE, Murgo JP. Effects of cardiac rehabilitation and exercise programs on exercise capacity, coronary risk factors, behavior, and quality of life in patients with coronary artery disease. South Med J. 1997;
90: 43-49.
6. Bloomquist CG, Saltin B. Cardiovascular adaptations to physical exercise. Ann Rev Physiol. 2009; 45: 169-189.
7. Goldsmith RL, Bigger JT Jr, Steineman RC, Fleiss JL. Comparison of 24-hour parasympathetic activity in endurance trained and untrained young men. J Am Coll Cardiol. 2016; 20: 552-558.
8. Brown M, Brown D, Murphy M.
Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N England J Med. 1983; 309(23): 1414-1419.
9. Cohn JN. Plasma noradrenaline and mortality. Clin Cardiol. 2011; 1: 9-12.
10.Billman GE. Heart rate response to the onset of exercise: evidence for enhanced cardiac sympathetic activity in animals susceptible to ventricular fibrillation. Am J Physiol Heart Circ Physiol. 2006; 291: 429- 435.
11.Mangin L, Swynghedauw B, Benis A, Thibault N, Lerebours G, Carré F.
Relationships between heart rate and heart rate variability: study in conscious rats. J Cardiovascular Pharmacol. 1998; 32(4):
601-607.
12.Billman GE. A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death.
Pharmacol Therap. 2006; 111: 808-835.
13.Barbier J, Rannou-Bekono F, Marchais J, Berthon PM, Delamarche P, Carr ÉF. Effect of training on beta1 beta2 beta3 adrenergic and M2 muscarinic receptors in rat heart.
Med Sci Sport Exerc. 2004; 36(6): 949-954.
14.Aubert AE, Seps B, Beckers F. Heart rate variability in athletes. Sports Med. 2003;
33: 889-919.
15.Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD.
Autonomic mechanisms and sudden death.
New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation. 1988;
78(4): 969-979.
16.Battes LC, Pedersen SS, Oemrawsingh RM, van Geuns RJ, Al Amri I, Regar E, et al.
Beta blocker therapy is associated with reduced depressive symptoms 12months post percutaneous coronary intervention. J Affect Dis. 2012; 136(3): 751-757.
17.Anderson JW, Lambert EA, Sari CI, Dawood T, Esler MD, Vaddadi G, et al.
Cognitive function, health-related quality of life, and symptoms of depression and
anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS). Frontiers in physiology.
2014; 5: 67-73.
18.De Schryver C, Mertens-Stryhagen J. Heart tissue acetylcholine in chronically exercised rats. Experientia. 1972; 31: 316-321.
19.Koob GF. Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry.
1999; 46: 1167-1180.
Evaluation and comparison of endurance training with fluoxetine
supplementation 4 weeks on depression and heart 1β adrenergic receptors in male Wistar rats
Kohneshin B*1, Piree M2, Matinhomaee H3
1. PhD Student in Sport Physiology, Department of Physiology,Faculty of Physical Education , Azad university of Tehran, Tehran, [email protected].
2. Full Professor, Department of Physiology,, Faculty of Physical Education , Azad University Of Tehran, Tehran, Iran.
3. Associate Professor, Department of Physiology, , Facultyof Physical Education ,, Azad University of Tehran, Tehran, Iran.
Received: 3 April 2017 Accepted: 17 May 2017
Abstract
Background : Long-term exposure to anxiety and depression puts myocardium at risk of failure.
Neurohormone Message caused be depression delivered to the heart by beta1 adrenoreceptor. The aim of this study was to survey and compare the effect of 4 weeks of endurance training with fluoxetine treatment on beta-adrenergic receptors in the male Wistar rat heart.
Materials and Methods: This research method is experimental. In this study, 24 male Wistar rats divided randomly into three groups. To each of the rats, exercise and supplementation group, fluoxetine 0.8 mg /kg of body weight LPS injected Intraperitoneal. Exercise group run for the 4- week on the treadmill at a speed of 20 meters per minute for 45 minutes each day. Fluoxetine group received 0.5 mg of oral fluoxetine. To prove the effects of LPS injection per and post FST test results analyzed using T-test for dependent samples. Pre and post-test FST data for each group using T-test at a significance level( α <0.05), and cardiac receiver data were analyzed by one-way ANOVA.
Results: The mean density of beta-1 adrenergic receptors in the training group were significantly lower than the depressed group (P <0.05). The mean density of beta-1 adrenergic receptors in the training group were not significant in comparison to the fluoxetine group.
Conclusion: Endurance training can prevent a significant increase in the density of adrenergic beta-1 receptors in the heart of the depressed rats.
Keywords: Intense Endurance Exercise, Beta-1 Adrenergic Receptor, FST Test.
*Citation: Kohneshin B, Piree M, Matinhomaee H. Evaluation and Comparison of endurance training with fluoxetine supplementation 4 weeks on depression and heart 1β adrenergic receptors in male Wistar rats. Yafte. 2017; 19(2):72-81.
